title: In vitro activities of trioxaquines against Schistosoma mansoni.
abstract: We report the in vitro activities of trioxaquines against larval and adult-stage schistosomes at 5 and 50 microg/ml, respectively. Such activities are equivalent to that of praziquantel, the major and rather unique drug currently used for the treatment of schistosomiasis. In this range of concentrations, artemisinin derivatives (artesunate and artemether) have no activity.
authors: UMR 5244 CNRS-UPVD-EPHE, Laboratoire de Biologie et d'Ecologie Tropicale et Méditerranéenne, Université de Perpignan, 52 avenue Paul Alduy, 66860 Perpignan, France.
authors: Jérôme
authors: J
authors: Boissier
authors: Frédéric
authors: F
authors: Coslédan
authors: Anne
authors: A
authors: Robert
authors: Bernard
authors: B
authors: Meunier
mesh_terms: D000634:Aminoquinolines / Q000494:pharmacology*; D000818:Animals; D006571:Heterocyclic Compounds / Q000494:pharmacology*; D007814:Larva / Q000187:drug effects; D051379:Mice; D021261:Parasitic Sensitivity Tests; D012555:Schistosomiasis mansoni / Q000188:drug therapy*; D012556:Schistosomicides / Q000494:pharmacology*
chemical_list: C503429:1,2,4-trioxane; D000634:Aminoquinolines; D006571:Heterocyclic Compounds; D012556:Schistosomicides; C001920:4-aminoquinoline